160
Participants
Start Date
November 24, 2015
Primary Completion Date
May 9, 2019
Study Completion Date
May 9, 2019
Alpha Neurology, Staten Island
Five Towns Neurology, Woodmere
Strotira, Inc., New York
Neurology and Stroke Associates, Lititz
Irene Greenhouse MD, Jamison
Optimum Neurology, Bala-Cynwyd
D. Gary Kolva, MD, Neurology, West Reading
MedStar Health, Washington D.C.
International Neurorehabilitation Institute, Lutherville
University System of Maryland, Baltimore
Dominion Neurological Services, Richmond
Braunstein Neurology, Mooresville
Colonial Healthcare, Sumter
Neurology of Central Georgia, Macon
Meridian Clinical Research, Savannah
Columbus Research & Wellness Institute, Columbus
Neurology Associates of Ormond Beach, Ormond Beach
Neurology Associates, Maitland
Neurological Services of Orlando, Orlando
Emery Neuroscience Center, Lighthouse PT
Cordova Research Institute, Miami
Infinity Clinical Research, Sunrise
Collier Neurologic Specialists, Naples
Negroski, Sutherland and Hanes Neurology, Sarasota
Florida Neurological Center, Ocala
Alabama Neurology Associates, Homewood
The Toledo Clinic, Toledo
Oak Clinic for Multiple Sclerosis, Uniontown
Detroit Clinical Research Center, Farmington Hills
College Park Family Care Center, Overland Park
Advanced Neurosciences Research, Fort Collins
Colorado Springs Neurological Associates, Colorado Springs
Ogden Clinic, Ogden
Territory Neurology & Research Institute, Tucson
Associated Neurologists of Southern Connecticut, Fairfield
Neurology Center of New England, Foxborough
Milford Regional Medical Center, Hopedale
CentraState Medical Center, Freehold
Lead Sponsor
Collaborators (1)
Mallinckrodt ARD Inc.
UNKNOWN
Mallinckrodt
INDUSTRY